Detalhe da pesquisa
1.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 402(10404): 775-785, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516125
2.
Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study.
J Headache Pain
; 25(1): 46, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561692
3.
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy.
Cephalalgia
; 43(2): 3331024221146315, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759320
4.
Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine aura.
Eur J Neurol
; 30(10): 3322-3331, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37489579
5.
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.
Headache
; 63(1): 79-88, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651532
6.
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
Headache
; 63(6): 730-742, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37313616
7.
Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience.
J Headache Pain
; 24(1): 16, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843007
8.
Impact of a reimbursement policy change on treatment with erenumab in migraine - a real-world experience from Germany.
J Headache Pain
; 24(1): 144, 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899428
9.
Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment.
J Headache Pain
; 24(1): 115, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612633
10.
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
J Headache Pain
; 24(1): 56, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208596
11.
The sense of stopping migraine prophylaxis.
J Headache Pain
; 24(1): 9, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792981
12.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine.
J Headache Pain
; 24(1): 128, 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723437
13.
Serum tau protein elevation in migraine: a cross-sectional case-control study.
J Headache Pain
; 24(1): 130, 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726712
14.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
J Headache Pain
; 24(1): 39, 2023 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038134
15.
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.
J Headache Pain
; 24(1): 134, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37814223
16.
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
J Headache Pain
; 24(1): 140, 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884869
17.
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study.
J Neurol Neurosurg Psychiatry
; 93(3): 254-262, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845002
18.
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.
Cephalalgia
; 42(4-5): 326-334, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34579559
19.
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
Cephalalgia
; 42(1): 20-30, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644189
20.
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study.
Cephalalgia
; 42(4-5): 291-301, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644203